Subsidiaries

BioTime and its subsidiary companies are committed to delivering novel products based on regenerative medicine to patients with serious diseases and degenerative conditions for which there are no cures.


Asterias Biotherapeutics, Inc.<br>NYSE MKT: AST

Asterias Biotherapeutics, Inc.
NYSE MKT: AST

Asterias Biotherapeutics, Inc., is advancing its pluripotent stem cell-based therapies in the world’s first human embryonic stem cell-based human clinical trial. AST-OPC1 is in a Phase I trial for spinal cord injury rehabilitation and AST-VAC2 is advancing toward clinical development for non-small cell lung cancer.

OncoCyte Corporation <br> NYSE MKT: OCX

OncoCyte Corporation
NYSE MKT: OCX

OncoCyte Corporation is focused on developing proprietary diagnostic products to meet unmet needs in the detection and screening of lung, breast and bladder cancer.

LifeMap Solutions

LifeMap Solutions

LifeMap Solutions is developing innovative mobile health (mHealth) solutions in collaboration with Mount Sinai, Stanford, Apple and 23andMe to deliver digital health solutions that empower patients to make better choices to achieve optimal health outcomes.

Ascendance Biotechnology

Ascendance Biotechnology

Combining the technologies of Hepregen Corporation and ESI BIO for innovative turn-key solutions for use in drug screening, predictive analysis and basic research.

Cell Cure Neurosciences Ltd.

Cell Cure Neurosciences Ltd.

Cell Cure Neurosciences Ltd., is entering Phase I/IIa clinical development of OpRegen®, human embryonic stem cell-derived retinal pigment epithelial cells, for the treatment of the dry form of age-related macular degeneration (AMD).

OrthoCyte Corporation

OrthoCyte Corporation

OrthoCyte Corporation is the world’s largest selection of pure musculo-skeletal progenitor stem cells lines provided through BioTime's PureStem embryonic progenitors. OrthoCyte Corporation is developing cellular therapies designed to reverse damage in the spine from age-related injuries.

LifeMap Sciences

LifeMap Sciences

LifeMap Sciences offers the GeneCards Suite, an integrated biomedical knowledgebase with premium tools that enable biomedical researchers to navigate the universe of human genes, proteins, cells, biological pathways, diseases, and study the relationships between them.

ReCyte Therapeutics, Inc.

ReCyte Therapeutics, Inc.

ReCyte Therapeutics, Inc., is focused on regenerative medicine for cardiovascular and metabolic diseases. We are developing cell-based and secreted product therapeutics using highly pure and scalable PureStem® progenitor stem cell lines. These lines have significant advantages including safety, reliability, and ease of manufacturing.